Moderna’s COVID-19 Vaccine Candidate Elicits Immune Response in Older Adults By Brian Park, PharmD Publish Date September 30, 2020
OTC Medicines Containing “Clean” Inactive Ingredients Launched By Steve Duffy Publish Date September 30, 2020
FDA Issues Complete Response Letter for Libervant By Brian Park, PharmD Publish Date September 30, 2020
Elezanumab Granted Orphan Drug, Fast Track Designations for Spinal Cord Injury By Brian Park, PharmD Publish Date September 30, 2020
Xeljanz Approved for Active Polyarticular Course Juvenile Idiopathic Arthritis By Brian Park, PharmD Publish Date September 29, 2020
Haegarda Approved for Pediatric Hereditary Angioedema By Brian Park, PharmD Publish Date September 29, 2020
Clinical Program for Investigational GERD Drug Discontinued By Diana Ernst, RPh Publish Date September 29, 2020
Only Two-Thirds of Parents Planning to Get Flu Shots for Their Children Publish Date September 29, 2020
Fetroja Approved for Hospital-Acquired, Ventilator-Associated Bacterial Pneumonia By Brian Park, PharmD Publish Date September 28, 2020
FDA Approves Nucala for Hypereosinophilic Syndrome By Brian Park, PharmD Publish Date September 28, 2020
Kalydeco Approval Expanded to Include Younger Cystic Fibrosis Patients By Diana Ernst, RPh Publish Date September 28, 2020
Preservative-Free Alaway Gets FDA Approval for OTC Use By Diana Ernst, RPh Publish Date September 28, 2020
